Summary.-The binding of human immunoglobulin to Type C viruses has been analysed by radioimmunoassay. The assay is a double-antibody, solid-phase RIA, which has been optimized and calibrated using rabbit and human anti-MuLV sera.
SERO -EPIDEMIOLOGY provides important clues to the possible activity of oncogenic viruses in man. It is largely on this basis that Epstein-Barr virus has been identified, not only as the cause of infectious mononucleosis (Niederman et al., 1970) but also as a likely cause of Burkitt's lymphoma (de and nasopharyngeal carcinoma (Henle & Henle, 1976) . This type of evidence has also been important in detecting endogenous and exogenous Type C virus activity in animals (Charman et al., 1975; Jhle et al., 1976; Nowinski & Kaehler, 1974) . Any claim for serological evidence of Type C virus in man (Kurth et al., 1977) therefore deserves careful scrutiny.
The widespread presence of anti-Type C virus antibodies in the human population (healthy and cancer patients) has been described (Aoki et al., 1976; Caldwell et al., 1975 : Kurth et al., 1977 Kurth & Mikschy, 1978; Loui et al., 1976; Snyder et al., 1976) , but also questioned (Gardner et al., 1977 ; Krakower & Aaronson, 1978 : Stephenson & Aaronson, 1976 . In the absence of a Type C virus of indisputable origin, proteins from well characterized mammalian Type C viruses have been used in the above studies. As most of these viruses are immunologically and biochemically similar, it was hoped that a putative human virus would follow the same pattern. The discrepancies between the reports have been ascribed to the use of different techniques, viral antigens and serum samples (Kurth et al., 1977; Kurth & Mikschy, 1978) . Moreover, the specificity of these antibodies has been questioned (Hogg et al., 1979; Snyder et al., 1976) .
A further investigation of the occurrence and specificity of antibodies to these viruses in man has accordingly been carried out. This started with the aim of carrying out sero-epidemiology, but developed into a critical study of the specificity of the antibodies involved. The virus chosen as the basis for the assay was HL-23V-1 virus, isolated from a human leukaemic cell line and known to be similar to nonhuman primate viruses (Chan et al., 1976; Okabe et al., 1976; Teich et al., 1975 ). Sera were also tested for reactivity to murine Moloney leukaemia virus (M-MuLV) and to avian virus, the Prague strain of Rous sarcoma virus (RSV) Subgroup A. A simplified double-antibody solid-phase radioimmunoassay was developed and standardized. Binding activity was detected in a large number of normal human sera. Inhibition studies indicate that this binding was directed at the carbohydrates of viral glycoproteins, and was nonspecific in character. These findings have been reported in abstract (Russell et al., 1979) . Similar conclusions have been reached in recent studies using radioimmuno-precipitation rather than solidphase assays (Barbacid et al., 1980; Snyder & Fleissner, 1980) .
METHODS
The following cell lines were used: NIH/ 3T3, mouse fibroblast; NRK, rat kidney; KNRK, NRK transformed by murine sarcoma virus (MSV) Kirsten strain; 1OK, KNRK infected with HL-23V-1 (Teich et al., 1975) ; 7605L, human diploid fibroblasts; XC (Svoboda, 1960; Rowe et al., 1970) . Cells were routinely grown in Dulbecco's modification of Eagle's medium supplemented with 10% foetal calf serum (FCS) .
HL-23V-1 and the Moloney strain of mouse leukaemia virus (M-MuLV) were pelleted respectively from supernatants of 1OK and NIH/3T3 (M-MuLV-infected) cell lines and then purified in sucrose-density gradients. The-Prague strain of Rous sarcoma virus Subgroup A (RSV) was purified from supernatant of virus-infected chicken embryo fibroblast culture. This medium was supplemented with 10% tryptose phosphate broth, 1% chicken serum and 1% FCS. Feline leukaemia virus (FeLV-A/F422) produced from a cell line derived from a cat lymphoma, was received from Dr 0. Jarrett (Glasgow).
After dialysis against phosphate-buffered saline (PBS), viral protein concentration was determined by the Lowry method and the viruses kept in aliquots at -70°C.
Proteins were obtained from the following (Hersh et al., 1974) .
Rabbit anti-HL-23V-1 and anti-M-MuLV were prepared by s.c. injection of 400 ,ug of virus protein in complete Freund's adjuvant, followed by 200 ,ug of protein in incomplete Freund's adjuvant at 3 weekly intervals. Rabbit anti-Ig antibodies were purified by affinity chromatography. Antibodies and viruses were labelled by the chloramine T method (Greenwood et al., 1963) .
In the binding assay, virus was first disrupted by freezing and thawing x 10. To each well of a flexible polyvinyl chloride "U" microtitration plate (Cooke) 1 jtg of viral protein in 50 Jul of PBS was added. After adsorbing overnight at room temperature the plates were washed in PBS and used or stored at -70°C. Before use, to minimize nonspecific binding, wells were filled with 100 jil of 4% human serum albumin (HSA, chosen because this protein does not competitively inhibit binding) in PBS and incubated for 1 h at 37°C. The plates were washed again and 50 ,ul of the antiserum dilutions in 2% HSA were added in triplicate and incubated for 1 h at 37°C, or overnight at 4°C, as indicated. After further washing, the plates were incubated for 1 h at 37°C with 50 ,ul/well of 1251-labelled anti-Ig antibody (16 ng) in 2% HSA. After final washing, wells were cut out and counted in a gamma counter. The figures show specific binding, given by subtracting the background binding to wells not coated with antigen from the binding in the presence of antigen. Titres are given by the inverse of the dilution giving 50% of the maximumIi binidiuig of the labelled second antibody. At the 5000 end point the assay detects 150 ng of purified antibody/ml of serum. In order to test for cross-reactivity between positive human sera and rabbit anti-viral sera, virus-coated plates w,ere preincubated for 1 h either wNith first human then rabbit serum, or vice versa. Competition was carried out by pre-incubating sera at their 5000 endpoint with increasing dilutions of antigen or monosaccharides. Incubation was carried out in microtubes at 4°C for 3 h, or as indicated, and NAas slightly higher at this than at room temnperature. After centrifugation the standard binding assay was performed. Maximunm binding was given by the unabsorbed samples. WA'hen human sera were tested for the presence of antigen(s) Ig was removed from sera by affinity chromatography.
Neutralization of HL-23V-1 infectivity was measured by the XC cell cytopathogenicity assay (Rowe et al., 1970) (Fig.  2a) . So did M-MuLV with selected normal human serum, and to a lesser e.xtent so did RSV, but not a control protein, tetanus toxoid (Fig. 2b) . A variety of glycoproteins and sera were then tested for competitive activity with selected normal human sera: BSA, fetuin, a2-macroglobulin and purified gp7O of HL-23V-1 proved active (e.g. 2%o BSA gave 18%o inhibition) and only HSA was inactive, as would be expected from the design of the assay. Other non-glycosylated proteins, besides tetanus toxoid and ribonucleases A and B, proved inactive, as did purified p30 of HL-23V-1. FCS and normal rabbit serum were both active, inhibiting by 44-5900 at a concentration of 500o. Reversing the assay, HL-23V-1 proved able to block the binding of human Igs to x2-macroglobulin adsorbed on to plates.
Intact cells were next examined for competitive activity. The mouse and rat cell lines could all absorb activity from selected normal human Igs, but not from rabbit anti-HL-23V-1 serum. In order to evaluate the importance of material picked up from the medium, cells were grown in media containing either FCS or in human serum selected for low reactivity towards HL-23V-1. KNRK cells grown under either condition removed all binding activity, whilst human 7605L cells, whether grown in FCS, human serum, or infected with HL-23V-1, did not remove the activity significantly (Fig. 3) OZ2-rhamnose) were not. In one experiment performed with U2-macroglobuhin-adsorbed plates, and the same serum end-point dilution, a mixture of the 3 abovementioned sugars showed an adsorption of 80% at a concentration of 2 mm.
In further confirmation of the distinction in specificity between normal human serum and rabbit anti-HL-2VI serum, the 2 types of serum did not compete with one another in binding to virus (Fig. 4) .
In an attempt to identify further the viral components to which normal human Ig bind, virus eluted from sepharosebound pooled human Ig were run in 10% acrylamide gel. Only one band co-migrated . ized with R-MuLV (Hersh et al., 1974; Charman et al., 1975) were tested in the < assay, with similar results (Fig. 6) (Kurth et al., 1977; Kurth & Mikschy, 1978) . Our interpretation of this binding is, however, very difficult, and conforms with that offered in more recent work (Barbacid et al., 1980; Snyder & Fleissner, 1980 (Yamaga et al., 1977) .
Our conclusions agree with those of Barbacid et al. (1980) and Snyder & Fleissner (1980) . We think it important to provide data based on a solid-phase assay, which avoids the criteria devolved at precipitation assays. The problem of trapping irrelevant proteins in the immune complexes at high serum concentrations (Charman & Gilden, 1978) does not apply here. Thus, solid-phase assays should be useful in any futuire search for truly virusspecific antibody.
The possibility that man is a nonresponder to Type C viral proteins can be eliminated. In this study sera obtained from individuals before and after vaccination with Rauscher-MuLV were tested for reactivity to Moloney MuLV, which shares antigenicity with R-MuLV7. Both pre-and post-vaccination sera contained antibodies of the type detected in the rest of this report. However, after removal of this reactivity by absorption with either KNRK cells or rabbit red cells, detectable anti-Moloney viral antibodies remained in post-vaccination sera but not in the prevaccination sera (Fig. 6 ). Thus, man is able to respond specifically to Type C virus if brought into contact with it, and this humoral response can be detected in the radioimmunoassay used in this study.
We therefore conclude that the immunoglobulin present in human serum which binds to retroviruses is anti-carbohydrate in nature, poorly specific, and cannot be taken as evidence of retrovirus infection.
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